Work

A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma

Year: 2016

Type: article

Source: Leukemia

DOI: 10.1038/leu.2016.255

Authors: N M Reddy, J P Greer, D S Morgan, H Chen, S I Park, K L Richards

Institutions: Vanderbilt University Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Weill Cornell Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Center for Research Resources

Awards: The Vanderbilt Institute for Clinical and Translational Research (VICTR) UL1, Vanderbilt Clinical Oncology Research Career Development Award

OpenAlex ID: W2522108802

FWCI: 4.235

Cites: 17

Cited by: 25

Related to: 10